Vaxxas

47 Thorndike Street
Suite B1-1
Cambridge
Massachusetts
MA-02141
United States

Activities

Related Content

Australian researchers use Nanopatch to deliver polio vaccine

Vaxxas raises AS$25m to accelerate commercialisation of novel vaccine platform

Vaxxas research project aims to advance next-generation technology for polio vaccine delivery

Vaxxas agrees Nanopatch collaboration with Merck

Jobs and People

Vaxxas appoints David Hoey as chief executive

Similar Companies